Extended follow-up of a phase 3 trial in relapsed multiple myeloma: final time-to-event results of the APEX trial

Initial analysis of the Assessment of Proteasome Inhibition for Extending Remissions (APEX) trial of relapsed multiple myeloma patients showed significantly longer time to progression, higher response rate, and improved survival with single-agent bortezomib versus high-dose dexamethasone. In this up...

Full description

Saved in:
Bibliographic Details
Main Authors: Richardson, Paul G. (Author) , Sonneveld, Pieter (Author) , Schuster, Michael (Author) , Irwin, David (Author) , Stadtmauer, Edward (Author) , Facon, Thierry (Author) , Harousseau, Jean-Luc (Author) , Ben-Yehuda, Dina (Author) , Lonial, Sagar (Author) , Goldschmidt, Hartmut (Author) , Reece, Donna (Author) , Miguel, Jesus San (Author) , Bladé, Joan (Author) , Boccadoro, Mario (Author) , Cavenagh, Jamie (Author) , Alsina, Melissa (Author) , Rajkumar, S. Vincent (Author) , Lacy, Martha (Author) , Jakubowiak, Andrzej (Author) , Dalton, William (Author) , Boral, Anthony (Author) , Esseltine, Dixie-Lee (Author) , Schenkein, David (Author) , Anderson, Kenneth C. (Author)
Format: Article (Journal)
Language:English
Published: [15 November 2007]
In: Blood
Year: 2007, Volume: 110, Issue: 10, Pages: 3557-3560
ISSN:1528-0020
DOI:10.1182/blood-2006-08-036947
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1182/blood-2006-08-036947
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0006497120422608
Get full text
Author Notes:Paul G. Richardson, Pieter Sonneveld, Michael Schuster, David Irwin, Edward Stadtmauer, Thierry Facon, Jean-Luc Harousseau, Dina Ben-Yehuda, Sagar Lonial, Hartmut Goldschmidt, Donna Reece, Jesus San Miguel, Joan Bladé, Mario Boccadoro, Jamie Cavenagh, Melissa Alsina, S. Vincent Rajkumar, Martha Lacy, Andrzej Jakubowiak, William Dalton, Anthony Boral, Dixie-Lee Esseltine, David Schenkein, and Kenneth C. Anderson

MARC

LEADER 00000caa a2200000 c 4500
001 1786940892
003 DE-627
005 20220820112705.0
007 cr uuu---uuuuu
008 220121s2007 xx |||||o 00| ||eng c
024 7 |a 10.1182/blood-2006-08-036947  |2 doi 
035 |a (DE-627)1786940892 
035 |a (DE-599)KXP1786940892 
035 |a (OCoLC)1341439033 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Richardson, Paul G.  |e VerfasserIn  |0 (DE-588)1073660222  |0 (DE-627)829311114  |0 (DE-576)435237594  |4 aut 
245 1 0 |a Extended follow-up of a phase 3 trial in relapsed multiple myeloma  |b final time-to-event results of the APEX trial  |c Paul G. Richardson, Pieter Sonneveld, Michael Schuster, David Irwin, Edward Stadtmauer, Thierry Facon, Jean-Luc Harousseau, Dina Ben-Yehuda, Sagar Lonial, Hartmut Goldschmidt, Donna Reece, Jesus San Miguel, Joan Bladé, Mario Boccadoro, Jamie Cavenagh, Melissa Alsina, S. Vincent Rajkumar, Martha Lacy, Andrzej Jakubowiak, William Dalton, Anthony Boral, Dixie-Lee Esseltine, David Schenkein, and Kenneth C. Anderson 
264 1 |c [15 November 2007] 
300 |b Diagramme 
300 |a 4 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 21.01.2022 
520 |a Initial analysis of the Assessment of Proteasome Inhibition for Extending Remissions (APEX) trial of relapsed multiple myeloma patients showed significantly longer time to progression, higher response rate, and improved survival with single-agent bortezomib versus high-dose dexamethasone. In this updated analysis (median follow-up: 22 months), survival was assessed in both arms, and efficacy updated for the bortezomib arm. Median survival was 29.8 months for bortezomib versus 23.7 months for dexamethasone, a 6-month benefit, despite substantial crossover from dexamethasone to bortezomib. Overall and complete response rates with bortezomib were 43% and 9%, respectively; among responding patients, 56% improved response with longer therapy beyond initial response, leading to continued improvement in overall quality of response. Higher response quality (100% M-protein reduction) was associated with longer response duration; response duration was not associated with time to response. These data confirm the activity of bortezomib and support extended treatment in relapsed multiple myeloma patients tolerating therapy. This study is registered at http://clinicaltrials.gov (Study ID NCT00048230). 
700 1 |a Sonneveld, Pieter  |e VerfasserIn  |4 aut 
700 1 |a Schuster, Michael  |e VerfasserIn  |4 aut 
700 1 |a Irwin, David  |e VerfasserIn  |4 aut 
700 1 |a Stadtmauer, Edward  |e VerfasserIn  |4 aut 
700 1 |a Facon, Thierry  |e VerfasserIn  |4 aut 
700 1 |a Harousseau, Jean-Luc  |e VerfasserIn  |4 aut 
700 1 |a Ben-Yehuda, Dina  |e VerfasserIn  |4 aut 
700 1 |a Lonial, Sagar  |e VerfasserIn  |4 aut 
700 1 |a Goldschmidt, Hartmut  |d 1956-  |e VerfasserIn  |0 (DE-588)102258023X  |0 (DE-627)717003809  |0 (DE-576)365637386  |4 aut 
700 1 |a Reece, Donna  |e VerfasserIn  |4 aut 
700 1 |a Miguel, Jesus San  |e VerfasserIn  |4 aut 
700 1 |a Bladé, Joan  |e VerfasserIn  |4 aut 
700 1 |a Boccadoro, Mario  |e VerfasserIn  |4 aut 
700 1 |a Cavenagh, Jamie  |e VerfasserIn  |4 aut 
700 1 |a Alsina, Melissa  |e VerfasserIn  |4 aut 
700 1 |a Rajkumar, S. Vincent  |e VerfasserIn  |4 aut 
700 1 |a Lacy, Martha  |e VerfasserIn  |4 aut 
700 1 |a Jakubowiak, Andrzej  |e VerfasserIn  |4 aut 
700 1 |a Dalton, William  |e VerfasserIn  |4 aut 
700 1 |a Boral, Anthony  |e VerfasserIn  |4 aut 
700 1 |a Esseltine, Dixie-Lee  |e VerfasserIn  |4 aut 
700 1 |a Schenkein, David  |e VerfasserIn  |4 aut 
700 1 |a Anderson, Kenneth C.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Blood  |d Washington, DC : American Society of Hematology, 1946  |g 110(2007), 10, Seite 3557-3560  |h Online-Ressource  |w (DE-627)266886647  |w (DE-600)1468538-3  |w (DE-576)075961938  |x 1528-0020  |7 nnas  |a Extended follow-up of a phase 3 trial in relapsed multiple myeloma final time-to-event results of the APEX trial 
773 1 8 |g volume:110  |g year:2007  |g number:10  |g pages:3557-3560  |g extent:4  |a Extended follow-up of a phase 3 trial in relapsed multiple myeloma final time-to-event results of the APEX trial 
856 4 0 |u https://doi.org/10.1182/blood-2006-08-036947  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S0006497120422608  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20220121 
993 |a Article 
994 |a 2007 
998 |g 102258023X  |a Goldschmidt, Hartmut  |m 102258023X:Goldschmidt, Hartmut  |d 910000  |d 910100  |d 50000  |e 910000PG102258023X  |e 910100PG102258023X  |e 50000PG102258023X  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 10 
999 |a KXP-PPN1786940892  |e 4040848004 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"eki":["1786940892"],"doi":["10.1182/blood-2006-08-036947"]},"relHost":[{"note":["Gesehen am 21.04.2023"],"origin":[{"publisher":"American Society of Hematology ; Saunders ; HighWire Press","dateIssuedKey":"1946","dateIssuedDisp":"1946-","publisherPlace":"Washington, DC ; Philadelphia, Pa. ; Stanford, Calif."}],"type":{"media":"Online-Ressource","bibl":"periodical"},"titleAlt":[{"title":"Blood online"}],"title":[{"title_sort":"Blood","subtitle":"journal of the American Society of Hematology","title":"Blood"}],"part":{"issue":"10","volume":"110","extent":"4","pages":"3557-3560","text":"110(2007), 10, Seite 3557-3560","year":"2007"},"language":["eng"],"corporate":[{"role":"isb","display":"American Society of Hematology"}],"disp":"Extended follow-up of a phase 3 trial in relapsed multiple myeloma final time-to-event results of the APEX trialBlood","id":{"zdb":["1468538-3"],"issn":["1528-0020"],"eki":["266886647"]},"physDesc":[{"extent":"Online-Ressource"}],"pubHistory":["1.1946 -"],"recId":"266886647"}],"recId":"1786940892","physDesc":[{"extent":"4 S.","noteIll":"Diagramme"}],"name":{"displayForm":["Paul G. Richardson, Pieter Sonneveld, Michael Schuster, David Irwin, Edward Stadtmauer, Thierry Facon, Jean-Luc Harousseau, Dina Ben-Yehuda, Sagar Lonial, Hartmut Goldschmidt, Donna Reece, Jesus San Miguel, Joan Bladé, Mario Boccadoro, Jamie Cavenagh, Melissa Alsina, S. Vincent Rajkumar, Martha Lacy, Andrzej Jakubowiak, William Dalton, Anthony Boral, Dixie-Lee Esseltine, David Schenkein, and Kenneth C. Anderson"]},"language":["eng"],"title":[{"title":"Extended follow-up of a phase 3 trial in relapsed multiple myeloma","title_sort":"Extended follow-up of a phase 3 trial in relapsed multiple myeloma","subtitle":"final time-to-event results of the APEX trial"}],"note":["Gesehen am 21.01.2022"],"origin":[{"dateIssuedDisp":"[15 November 2007]","dateIssuedKey":"2007"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"person":[{"role":"aut","given":"Paul G.","display":"Richardson, Paul G.","family":"Richardson"},{"given":"Pieter","role":"aut","family":"Sonneveld","display":"Sonneveld, Pieter"},{"display":"Schuster, Michael","family":"Schuster","role":"aut","given":"Michael"},{"given":"David","role":"aut","display":"Irwin, David","family":"Irwin"},{"role":"aut","given":"Edward","family":"Stadtmauer","display":"Stadtmauer, Edward"},{"family":"Facon","display":"Facon, Thierry","given":"Thierry","role":"aut"},{"family":"Harousseau","display":"Harousseau, Jean-Luc","given":"Jean-Luc","role":"aut"},{"family":"Ben-Yehuda","display":"Ben-Yehuda, Dina","role":"aut","given":"Dina"},{"role":"aut","given":"Sagar","display":"Lonial, Sagar","family":"Lonial"},{"role":"aut","given":"Hartmut","family":"Goldschmidt","display":"Goldschmidt, Hartmut"},{"given":"Donna","role":"aut","family":"Reece","display":"Reece, Donna"},{"display":"Miguel, Jesus San","family":"Miguel","role":"aut","given":"Jesus San"},{"role":"aut","given":"Joan","family":"Bladé","display":"Bladé, Joan"},{"given":"Mario","role":"aut","display":"Boccadoro, Mario","family":"Boccadoro"},{"family":"Cavenagh","display":"Cavenagh, Jamie","given":"Jamie","role":"aut"},{"family":"Alsina","display":"Alsina, Melissa","role":"aut","given":"Melissa"},{"role":"aut","given":"S. Vincent","display":"Rajkumar, S. Vincent","family":"Rajkumar"},{"role":"aut","given":"Martha","display":"Lacy, Martha","family":"Lacy"},{"role":"aut","given":"Andrzej","family":"Jakubowiak","display":"Jakubowiak, Andrzej"},{"role":"aut","given":"William","display":"Dalton, William","family":"Dalton"},{"display":"Boral, Anthony","family":"Boral","given":"Anthony","role":"aut"},{"given":"Dixie-Lee","role":"aut","display":"Esseltine, Dixie-Lee","family":"Esseltine"},{"role":"aut","given":"David","family":"Schenkein","display":"Schenkein, David"},{"family":"Anderson","display":"Anderson, Kenneth C.","given":"Kenneth C.","role":"aut"}]} 
SRT |a RICHARDSONEXTENDEDFO1520